Physician

Bahar Hadjiesmaeiloo, M.D.

According to 2025 Medicare claims, Bahar Hadjiesmaeiloo, M.D. (NPI: 1548585292) practices general psychiatry in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is OPTUM MEDICAL CARE OF NEW JERSEY PC (NPI: 1578665048; TIN: 223624559) and primary practice location at 07030-5505.

Hadjiesmaeiloo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 85 traditional Medicare patients, billed 432 HCPCS/CPT codes, and received $31,173 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,781 prescription claims across 209 beneficiaries totaling $315,845 in drug costs, led by Ingrezza (Valbenazine Tosylate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $27,241 to $31,173. In contrast, Part D prescription costs have risen steadily, from $5,617 to $315,845. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$48K$96K2015 Medicare payment: $27,241 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $71,174 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $95,945 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $70,663 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $75,332 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $29,668 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $46,709 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $40,823 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $23,834 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $31,173 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015186362$27,241
2016134942$71,174
20171971,376$95,945
20182031,037$70,663
20192071,115$75,332
2020129435$29,668
2021130542$46,709
2022129496$40,823
2023103316$23,834
202485432$31,173

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$252K$505K2015 Drug cost: $5,617 (USD; Tot_Drug_Cst)2016 Drug cost: $26,203 (USD; Tot_Drug_Cst)2017 Drug cost: $58,212 (USD; Tot_Drug_Cst)2018 Drug cost: $112,717 (USD; Tot_Drug_Cst)2019 Drug cost: $242,019 (USD; Tot_Drug_Cst)2020 Drug cost: $228,796 (USD; Tot_Drug_Cst)2021 Drug cost: $467,512 (USD; Tot_Drug_Cst)2022 Drug cost: $504,715 (USD; Tot_Drug_Cst)2023 Drug cost: $326,006 (USD; Tot_Drug_Cst)2024 Drug cost: $315,845 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152868$5,617
201697930$26,203
20171401,311$58,212
20182542,411$112,717
20192783,341$242,019
20202832,600$228,796
20212833,640$467,512
20222603,441$504,715
20232262,519$326,006
20242092,781$315,845

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more59143$96
90834Psychotherapy, 45 minutes1226$77
90832Psychotherapy, 30 minutes23118$62
90833Psychotherapy with evaluation and management visit, 30 minutes4176$55
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2743$47

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IngrezzaValbenazine Tosylate13390$92,813
Invega SustennaPaliperidone Palmitate25750$53,207
VraylarCariprazine Hcl17510$24,261
TrintellixVortioxetine Hydrobromide181,290$20,367
Lurasidone HclLurasidone Hcl271,050$19,621

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Bahar Hadjiesmaeiloo, M.D.?

Tedicare shows public-source Medicare data for Bahar Hadjiesmaeiloo, M.D. (NPI 1548585292), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bahar Hadjiesmaeiloo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bahar Hadjiesmaeiloo, M.D.?

Bahar Hadjiesmaeiloo, M.D. is linked to OPTUM MEDICAL CARE OF NEW JERSEY PC (billing NPI 1578665048) in the available physician profile data.

Does Bahar Hadjiesmaeiloo, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.